The Recall Desk
ModerateFDA (Devices)·Z-0820-2023·Announced 2023-01-11

FDA Recalls ETEST Clinical Benzylpenicil Test Due to Storage Excursion

Biomerieux Inc recalls ETEST Clinical Benzylpenicil susceptibility test kits due to temperature and time excursions during storage that affect product performance. Batch 1009477980 was distributed nationwide.

What this means for you

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: This is an FDA Class II recall with no reported illnesses or injuries. The hazard is potential performance degradation due to storage excursions; the risk is theoretical with no documented patient harm. Per the rubric, recalls with theoretical hazards and no reported harm are at most 3. The precautionary nature and absence of direct safety impact justify a Moderate (2) rating.

Plain-English summary

Biomerieux Inc is recalling ETEST CLINICAL BENZYLPENICIL PG 256 US S30 susceptibility testing kits (Catalog 412262, Batch 1009477980). These products are used in clinical microbiology laboratories.

The product was exposed to temperature and time excursions during storage that exceeded acceptable ranges. According to the FDA and manufacturer, product performance cannot be guaranteed under these conditions.

The affected batch was distributed nationwide in the United States. Laboratories and healthcare facilities that received this product are advised to contact Biomerieux Inc regarding returns, replacements, or further instructions.

The recalled product

Product
ETEST CLINICAL BENZYLPENICIL PG 256 US S30, CATALOG 412262
Manufacturer
Biomerieux Inc
Hazard
  • storage-excursion
  • performance-degradation

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (2)

  • UDI/DI 03573026376802
  • Batch Numbers: 1009477980

Distribution

Distributed nationwide across the United States.